智通财经APP讯,复宏汉霖(02696)发布公告,本公司已于近日接获中国证监会出具的《关于上海复宏汉霖生物技术股份有限公司境内未上市股份“全流通”备案通知书》(备案通知书)。根据备案通知书,本公司就本公司若干股东所持合计1.83亿股非上市股实施H股全流通向中国证监会的备案已完成。若本公司自备案通知书出具之日起12个月内未完成本次H股全流通转换及上市,拟继续推进的,应当向中国证监会更新备案材料。
智通财经APP讯,复宏汉霖(02696)发布公告,本公司已于近日接获中国证监会出具的《关于上海复宏汉霖生物技术股份有限公司境内未上市股份“全流通”备案通知书》(备案通知书)。根据备案通知书,本公司就本公司若干股东所持合计1.83亿股非上市股实施H股全流通向中国证监会的备案已完成。若本公司自备案通知书出具之日起12个月内未完成本次H股全流通转换及上市,拟继续推进的,应当向中国证监会更新备案材料。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.